Cargando…

Serum Metabolomic Analysis of Male Patients with Cannabis or Amphetamine Use Disorder

Studies have demonstrated that chronic consumption of abused drugs induces alterations in several proteins that regulate metabolism. For instance, methamphetamine exposure reduces glucose levels. Fatty and amino acid levels were altered in groups exposed to abused drugs. Therefore, in our study, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Alasmari, Fawaz, Assiri, Mohammed A., Ahamad, Syed Rizwan, Aljumayi, Sahar R., Alotaibi, Wedad H., Alhamdan, Majd M., Alhazzani, Khalid, Alharbi, Metab, Alqahtani, Faleh, Alasmari, Abdullah F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879674/
https://www.ncbi.nlm.nih.gov/pubmed/35208253
http://dx.doi.org/10.3390/metabo12020179
_version_ 1784658948915200000
author Alasmari, Fawaz
Assiri, Mohammed A.
Ahamad, Syed Rizwan
Aljumayi, Sahar R.
Alotaibi, Wedad H.
Alhamdan, Majd M.
Alhazzani, Khalid
Alharbi, Metab
Alqahtani, Faleh
Alasmari, Abdullah F.
author_facet Alasmari, Fawaz
Assiri, Mohammed A.
Ahamad, Syed Rizwan
Aljumayi, Sahar R.
Alotaibi, Wedad H.
Alhamdan, Majd M.
Alhazzani, Khalid
Alharbi, Metab
Alqahtani, Faleh
Alasmari, Abdullah F.
author_sort Alasmari, Fawaz
collection PubMed
description Studies have demonstrated that chronic consumption of abused drugs induces alterations in several proteins that regulate metabolism. For instance, methamphetamine exposure reduces glucose levels. Fatty and amino acid levels were altered in groups exposed to abused drugs. Therefore, in our study, we investigated the serum metabolomic profile of patients diagnosed with cannabis and/or amphetamine use disorders. Blood was obtained from subjects (control, amphetamine, and cannabis). Detection of serum metabolites was performed using gas chromatography. The ratio peak areas for metabolites were analyzed across the three groups. Both cannabis and amphetamine groups showed higher d-erythrotetrafuranose, octadecanoic acid, hexadecenoic acid, trans-9-octadecanoic acid, lactic acid and methyl thio hydantoin metabolites compared with the control group. Moreover, cannabis patients were found to possess higher glycine, 9,12 octadecanoic acid malonic acid, phosphoric acid and prostaglandin F1a than controls. Our analysis showed that the identified metabolic profile of cannabis or amphetamine use disorder patients was different than control group. Our data indicated that chronic exposure to cannabis or amphetamine dysregulated metabolites in the serum. Future studies are warranted to explore the effects of these abused drugs on the metabolic proteins.
format Online
Article
Text
id pubmed-8879674
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88796742022-02-26 Serum Metabolomic Analysis of Male Patients with Cannabis or Amphetamine Use Disorder Alasmari, Fawaz Assiri, Mohammed A. Ahamad, Syed Rizwan Aljumayi, Sahar R. Alotaibi, Wedad H. Alhamdan, Majd M. Alhazzani, Khalid Alharbi, Metab Alqahtani, Faleh Alasmari, Abdullah F. Metabolites Article Studies have demonstrated that chronic consumption of abused drugs induces alterations in several proteins that regulate metabolism. For instance, methamphetamine exposure reduces glucose levels. Fatty and amino acid levels were altered in groups exposed to abused drugs. Therefore, in our study, we investigated the serum metabolomic profile of patients diagnosed with cannabis and/or amphetamine use disorders. Blood was obtained from subjects (control, amphetamine, and cannabis). Detection of serum metabolites was performed using gas chromatography. The ratio peak areas for metabolites were analyzed across the three groups. Both cannabis and amphetamine groups showed higher d-erythrotetrafuranose, octadecanoic acid, hexadecenoic acid, trans-9-octadecanoic acid, lactic acid and methyl thio hydantoin metabolites compared with the control group. Moreover, cannabis patients were found to possess higher glycine, 9,12 octadecanoic acid malonic acid, phosphoric acid and prostaglandin F1a than controls. Our analysis showed that the identified metabolic profile of cannabis or amphetamine use disorder patients was different than control group. Our data indicated that chronic exposure to cannabis or amphetamine dysregulated metabolites in the serum. Future studies are warranted to explore the effects of these abused drugs on the metabolic proteins. MDPI 2022-02-14 /pmc/articles/PMC8879674/ /pubmed/35208253 http://dx.doi.org/10.3390/metabo12020179 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Alasmari, Fawaz
Assiri, Mohammed A.
Ahamad, Syed Rizwan
Aljumayi, Sahar R.
Alotaibi, Wedad H.
Alhamdan, Majd M.
Alhazzani, Khalid
Alharbi, Metab
Alqahtani, Faleh
Alasmari, Abdullah F.
Serum Metabolomic Analysis of Male Patients with Cannabis or Amphetamine Use Disorder
title Serum Metabolomic Analysis of Male Patients with Cannabis or Amphetamine Use Disorder
title_full Serum Metabolomic Analysis of Male Patients with Cannabis or Amphetamine Use Disorder
title_fullStr Serum Metabolomic Analysis of Male Patients with Cannabis or Amphetamine Use Disorder
title_full_unstemmed Serum Metabolomic Analysis of Male Patients with Cannabis or Amphetamine Use Disorder
title_short Serum Metabolomic Analysis of Male Patients with Cannabis or Amphetamine Use Disorder
title_sort serum metabolomic analysis of male patients with cannabis or amphetamine use disorder
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879674/
https://www.ncbi.nlm.nih.gov/pubmed/35208253
http://dx.doi.org/10.3390/metabo12020179
work_keys_str_mv AT alasmarifawaz serummetabolomicanalysisofmalepatientswithcannabisoramphetamineusedisorder
AT assirimohammeda serummetabolomicanalysisofmalepatientswithcannabisoramphetamineusedisorder
AT ahamadsyedrizwan serummetabolomicanalysisofmalepatientswithcannabisoramphetamineusedisorder
AT aljumayisaharr serummetabolomicanalysisofmalepatientswithcannabisoramphetamineusedisorder
AT alotaibiwedadh serummetabolomicanalysisofmalepatientswithcannabisoramphetamineusedisorder
AT alhamdanmajdm serummetabolomicanalysisofmalepatientswithcannabisoramphetamineusedisorder
AT alhazzanikhalid serummetabolomicanalysisofmalepatientswithcannabisoramphetamineusedisorder
AT alharbimetab serummetabolomicanalysisofmalepatientswithcannabisoramphetamineusedisorder
AT alqahtanifaleh serummetabolomicanalysisofmalepatientswithcannabisoramphetamineusedisorder
AT alasmariabdullahf serummetabolomicanalysisofmalepatientswithcannabisoramphetamineusedisorder